These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20299220)

  • 1. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
    Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Tan Q; Ogawa AM; Raghoobar SL; Wisniewski D; Colwell L; Park YW; Young K; Hermes JD; Dininno FP; Hammond ML
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4363-5. PubMed ID: 21664132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H
    Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomolar inhibitors of AmpC beta-lactamase.
    Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
    J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
    Brown S; Young HK; Amyes SG
    Clin Microbiol Infect; 2005 Jan; 11(1):15-23. PubMed ID: 15649299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
    Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
    Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.
    Chen H; Blizzard TA; Kim S; Wu J; Young K; Park YW; Ogawa AM; Raghoobar S; Painter RE; Wisniewski D; Hairston N; Fitzgerald P; Sharma N; Scapin G; Lu J; Hermes J; Hammond ML
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4267-70. PubMed ID: 21676616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
    Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
    J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
    Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei.
    Yang Z; Niu Y; Le Y; Ma X; Qiao C
    Phytomedicine; 2010 Feb; 17(2):139-41. PubMed ID: 19747808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-ketophosphonates as beta-lactamase inhibitors: Intramolecular cooperativity between the hydrophobic subsites of a class D beta-lactamase.
    Perumal SK; Adediran SA; Pratt RF
    Bioorg Med Chem; 2008 Jul; 16(14):6987-94. PubMed ID: 18572409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.
    Merkier AK; Centrón D
    Int J Antimicrob Agents; 2006 Aug; 28(2):110-3. PubMed ID: 16844350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of plasmid-mediated class C beta-lactamases.
    Doi Y; Paterson DL
    Int J Infect Dis; 2007 May; 11(3):191-7. PubMed ID: 17339123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
    Moloughney JG; D Thomas J; Toney JH
    FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
    Poirel L; Nordmann P
    Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of beta-lactamase inhibitors against Acinetobacter baumannii].
    Fernández Cuenca F
    Rev Esp Quimioter; 1998 Dec; 11(4):384-5. PubMed ID: 10336325
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallo-beta-lactamase inhibitors: promise for the future?
    Toney JH; Moloughney JG
    Curr Opin Investig Drugs; 2004 Aug; 5(8):823-6. PubMed ID: 15600238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.